Mapping antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli across low, middle and high-income countries highlights significant differences: insights for empiric treatment.
Rizvi M, Khan M, Al-Jardani A, Al-Abri SS, Ghoshal U, Jabri ZA, Ahanjan M, Mamari AA, Shizawi NA, Sami H, Balkhair A, Shaukat A, Alkharusi ANS, Almahrouqi A, Hassan A, Kumar A, Malehi AS, Gul A, Singh A, Shidhani ASHA, Siddiqui AH, Poojary A, Rashdi AA, Langford B, Stepanskyi D, Dolatabadi A, Maani AA, Mufarji AA, AlRisi ESA, Kapoor G, Princess I, Lawati HJA, Eltahir HA, Sidairi HA, Iskandar K, Masters K, Al-Busaidi IKH, Yazidi LA, Nasrin M, Subhi MSA, Sengupta M, Khandait M, Tamtami NKA, Siyabi NKA, Kindi NA, Luthfee NM, Shreshtha N, Riyami NMAA, Busaidi NHAA, Goel N, Ishchenko O, Taher OMEA, Jena PP, Ekadashi R, Al Zadjali R, Kanungo R, Abolghasemi S, Maqbali SA, Banerjee S, Yaqoob S, Sali S, Khan SH, Malhotra S, Hughes S, Shaukat S, Atif SM, Patwardhan VV, Dougnon V, Khan W, Wali W, Muharrmi ZA, Basit Z, Choudhury J, Pravalina R, John KHS, Singh S, Singh S, Taneja N, Sardana R, Ghafur A, Kapoor P, Soman R, Abri RA.
Rizvi M, et al. Among authors: sali s.
IJID Reg. 2025 Jul 17;16:100706. doi: 10.1016/j.ijregi.2025.100706. eCollection 2025 Sep.
IJID Reg. 2025.
PMID: 40822640
Free PMC article.
